Live from the NIH registry
Studies recruiting near Irvine right now
Top 25 of 1,516 recruiting studies, sorted by proximity — each links to its official registry page
Congenital Muscle Disease Study of Patient and Family Reported Medical Information
Multiple conditions
N/A
Observational 4,000 participants sought
Congenital Muscle Disease International Registry (www.cmdir.org) — Lakewood, California (24.0 mi)
· Sponsor: Cure CMD
A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)
B Acute Lymphoblastic Leukemia
Phase 2
Interventional 222 participants sought
Children's Hospital of Orange County — Orange, California (8.9 mi)
· Sponsor: National Cancer Institute (NCI)
Phase 2 Study to Evaluate EI-001 in Non-segmental Vitiligo Patients
Non-segmental Vitiligo
Phase 2
Interventional 45 participants sought
Marvel Clinical Research — Huntington Beach, California (13.0 mi)
· Sponsor: Elixiron Immunotherapeutics (Hong Kong) Ltd.
A Study of Zasocitinib in Adults With Hidradenitis Suppurativa
Hidradenitis Suppurativa
Phase 2
Interventional 90 participants sought
First OC Dermatology Research — Fountain Valley, California (10.6 mi)
· Sponsor: Takeda
A Study Assessing Corneal Endothelial Cells in Participants With Neovascular Age-related Macular Degeneration (nAMD) Treated With the Port Delivery System With Ranibizumab (PDS)
Neovascular Age-related Macular Degeneration
Phase 4
Interventional 188 participants sought
Orange County Retina Med Group — Santa Ana, California (7.2 mi)
· Sponsor: Genentech, Inc.
A Study to Evaluate the Safety of AB-1003 (Previously LION-101) in Subjects With Genetic Confirmation of LGMD2I/R9 (Part1)
Limb Girdle Muscular Dystrophy, Limb-Girdle Muscular Dystrophy Type 2
Phase 1, Phase 2
Interventional 10 participants sought
University of California - Irvine — Irvine, California (2.9 mi)
· Sponsor: AskBio Inc
DESTINY-Endometrial01: A Phase III Study of Trastuzumab Deruxtecan Plus Rilvegostomig or Pembrolizumab as First-Line Treatment of HER2-Expressing (IHC 3+/2+), Mismatch Repair Proficient (pMMR) Endometrial Cancer
Endometrial Cancer
Phase 3
Interventional 600 participants sought
Research Site — Irvine, California (2.9 mi)
· Sponsor: AstraZeneca
A Solid Tumor Study for Long Term Treatment of Cancer Patients Who Participated in Adagrasib Studies
Solid Tumors
Phase 2
Interventional 170 participants sought
Southern California Permanente Medical Group — Bellflower, California (24.3 mi)
· Sponsor: Mirati Therapeutics Inc.
ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation
Bladder Carcinoma, Ureter Carcinoma
N/A
Observational 2,020 participants sought
Hoag Memorial Hospital Presbyterian — Newport Beach, California (9.8 mi)
· Sponsor: Guardant Health, Inc.
A Study to Evaluate Safety, Tolerability and Efficacy of AP306 at Fixed Doses in Dialysis Participants With Hyperphosphatemia
Hyperphosphatemia, Chronic Kidney Disease Requiring Chronic Dialysis
Phase 2
Interventional 168 participants sought
North America Research Institute — San Dimas, California (29.7 mi)
· Sponsor: R1 Therapeutics
YAG Laser Vitreolysis for Vitreous Floaters
Posterior Vitreous Detachment, Myopic Vitreopathy
N/A
Interventional 50 participants sought
VMR Institute for Vitreous Macula Retina — Huntington Beach, California (13.0 mi)
· Sponsor: VMR Consulting, Inc.
Effect of Electro-Acupuncture on Blood Pressure
Hypertension
N/A
Interventional 160 participants sought
Susan Samueli Integrative Health Institute — Irvine, California (2.9 mi)
· Sponsor: University of California, Irvine
A Study of Vedolizumab With Tofacitinib in Adults With Ulcerative Colitis (UC)
Ulcerative Colitis
Phase 4
Interventional 65 participants sought
Hoag Hospital Newport Beach — Newport Beach, California (9.8 mi)
· Sponsor: Takeda
A Study of Cemiplimab Plus Chemotherapy Versus Cemiplimab Plus Chemotherapy Plus Other Cancer Treatments for Adult Patients With Operable Non-Small Cell Lung Cancer (NSCLC)
Non-Small Cell Lung Cancer
Phase 2
Interventional 120 participants sought
University of California Irvine — Orange, California (8.9 mi)
· Sponsor: Regeneron Pharmaceuticals
Gen 2 Battrode Wear Study
Adhesive Wear Time
N/A
Interventional 30 participants sought
Orange County Research Center — Lake Forest, California (5.3 mi)
· Sponsor: Baxter Healthcare Corporation
Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung Cancer
Previously Treated Non-Small Cell Lung Cancer
Phase 2, Phase 3
Interventional 10,000 participants sought
City of Hope at Irvine Lennar — Irvine, California (2.9 mi)
· Sponsor: SWOG Cancer Research Network
Treatment of Ocular Discomfort in Glaucoma Patients Using Multiple Topical Medications
Glaucoma, Ocular Surface Disease
N/A
Observational 75 participants sought
Doheny Eye Center UCLA — Fountain Valley, California (10.6 mi)
· Sponsor: University of California, Los Angeles
Inclisiran Versus Placebo for the Prevention of Major Adverse Cardiovascular and Limb Events in Patients Undergoing Percutaneous Coronary Intervention or Peripheral Endovascular Intervention
Percutaneous Coronary Intervention, Peripheral Endovascular Intervention
Phase 4
Interventional 6,000 participants sought
Radin Cardiovascular Medical Group, Inc — Newport Beach, California (9.8 mi)
· Sponsor: Duke University
A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract
Carcinoma, Transitional Cell, Urinary Bladder Neoplasms
Phase 3
Interventional 450 participants sought
Chao Family Comprehensive Cancer Center and Ambulatory Care (CIACC) - Irvine — Irvine, California (2.9 mi)
· Sponsor: Eli Lilly and Company
Isunakinra Alone and in Combination With Pembrolizumab in Patients With Colorectal Cancer (MSS)
Colorectal Cancer Metastatic
Phase 2
Interventional 20 participants sought
Hoag Memorial Hospital Presbyterian — Newport Beach, California (9.8 mi)
· Sponsor: Buzzard Pharmaceuticals
A Study of Oral Atogepant Tablets to Assess Adverse Events and Change in Disease Activity To Prevent Migraine in Participants Aged 12 to 17 Years
Chronic Migraine
Phase 3
Interventional 420 participants sought
Advanced Research Center /ID# 270257 — Anaheim, California (13.6 mi)
· Sponsor: AbbVie
Mobile Health Intervention to Improve Adherence to Oral Anticancer Therapy
Cancer, Neoplasms
N/A
Interventional 35 participants sought
Chao Family Comprehensive Cancer Center and Ambulatory Care building — Irvine, California (2.9 mi)
· Sponsor: University of California, Irvine
Recombinant Factor VIIa (rFVIIa) for Hemorrhagic Stroke Trial - Part 2
Intracerebral Hemorrhage
Phase 3
Interventional 350 participants sought
UC Irvine Medical Center, — Orange, California (8.9 mi)
· Sponsor: Joseph Broderick, MD
Study of Efficacy and Safety of Iptacopan in Participants With IC-MPGN
IC-MPGN
Phase 3
Interventional 106 participants sought
Univ Cali Irvine ALS Neuromuscular — Orange, California (8.9 mi)
· Sponsor: Novartis Pharmaceuticals
E-Mindfulness Approaches for Living After Breast Cancer
Breast Cancer, Depression
Phase 3
Interventional 402 participants sought
UCI Health - Chao Family Comprehensive Cancer Center and Ambulatory Care — Irvine, California (2.9 mi)
· Sponsor: NRG Oncology